RxDoctor Payments Data

Kristi Yearout, NP

Adult Health · Kamuela, HINPI 1558698878

Payments from drug & device makers

What this record shows

This record is dominated by other: $12,667 of the $15,722 with a category attached, or 80.6%. Angiodynamics, Inc. accounts for 80.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $10,260, more than ten times the $766 reported in 2022. Among adult health clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,722in general payments, 2019–2025

Across 68 payments — averaging $231.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$13K
  • Bard Peripheral Vascular, Inc.$1K
  • Boston Scientific$1K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$233
  • Amgen$162
  • Medtronic$126
  • plus $252 from 3 others

What the payments were for

  • Travel & lodging$3492%
  • Food & beverage$2,70617%
  • Other$12,66781%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,722 in reported general payments places this provider in the 95th percentile of 44 adult health providers in Hawaii.

See all adult health providers in Hawaii

Medicare billing

Part B allowed, 2024
$30,289
Medicare patients
96
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$79,907
Praluent PenAlirocumab44$28,081
Repatha SureclickEvolocumab21$12,519
Metoprolol Succinate150$2,644
Atorvastatin Calcium61$1,908
Rosuvastatin Calcium47$1,759
Amlodipine Besylate101$1,020
ClopidogrelClopidogrel Bisulfate20$816
Losartan Potassium57$774
Carvedilol42$385
Lisinopril45$373
Potassium Chloride13$290
Hydralazine Hcl24$180
Furosemide25$145
Ezetimibe15$82

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$97$79,90763 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 44 adult health providers in Hawaii.

Other adult health in Kamuela

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →